期刊文献+

缺失激素结合区的人糖皮质激素受体突变体的研究 被引量:1

Investigations of glucocorticoid receptor mutant without ligand binding domain
下载PDF
导出
摘要 目的:构建缺失激素结合区(LBD)的人糖皮质激素受体突变体表达载体,并研究其表达和功能。方法:运用RT-nested PCR扩增人糖皮质激素受体(GR)基因不含编码LBD的cDNA序列,将PCR产物定向克隆至pEGFP-N2质粒载体,测序筛选编码正确的重组质粒;荧光显微镜观察GR突变体重组质粒转染人巨噬细胞株U937后的表达情况;相对荧光素酶法检测转染后细胞GR转录激活活性。结果:扩增出长1601 bp的cDNA序列,测序证实:克隆片段与Genebank该基因序列同源性为100%;重组质粒表达产物定位于细胞核;转染组细胞GR转录激活活性增强。结论:成功构建缺失LBD的GR突变体表达载体,该突变体具有不依赖激素的GR转录激活活性。 Objectlve:To construct expression vector of human glucocorticoid receptor mutant. Methods :cDNA sequence of human glucocorticoid receptor mutant having no LBD was amplificated through RT-nested PCR, PCR product was directionaily cloned to pEGFP-N2 plasmid vector, and recombinant plasmids were screened through sequencing. Expressions of recombinant plasmids in human macrophage cell line U937 were observed through fluorescence microscope. Transcriptional activation activity of vailant was evaluated through was obtained, and result methods of relative activity of luciferase. Results :The 1601 bp length cDNA of sequencing confirmed the cloned cDNA sequence is completely coincidence with that of glucocorticoid receptor in Genebank. Expression products of recombinant plasmid mainly located in nucleus. Transcriptional activation activity incresed after recombinant plasmid transfected. Conclusion:Expression vector of glucocorticoid receptor mutant was constructed successfully, which has transcriptional activation activity independent of glucocorticoid.
出处 《医学研究生学报》 CAS 2007年第5期474-476,489,I0002,共5页 Journal of Medical Postgraduates
关键词 糖皮质激素受体 激素结合区 转录激活活性 Glucocorticoid receptor Ligand binding domain Transcriptional activation activity
  • 相关文献

参考文献12

  • 1Ito K,Chung KF,Adcock IM.Update on glucocorticoid action and resistance[J].J Allergy Clin Immunol,2006,117(3):522 -543.
  • 2Kumar R,Thompson EB.Gene regulation by the glucocorticoid receptor:structure:function relationship[J].J Steroid Biochem Mol Biol,2005,94(5):383-394.
  • 3Bledsoe RK,Stewart EL,Pearce KH.Structure and function of the glucocorticoid receptor ligand binding domain[J].Vitam Horm,2004,68(7):49-91.
  • 4Pratt WB,Galigniana,MD,Morishima Y,et al.Role of molecular chaperones in steroid receptor action[J].Essays Biochem,2004,40(3):41-58.
  • 5Buckbinder L,Robinson RP.The glucocorticoid receptor:molecular mechanism and new therapeutic opportunities[J].Curr Drug Inflamm Allergy,2002,1(2):127-136.
  • 6Charmandari E,Raji A,Kino T,et al.A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance:the importance of the C terminus of hGR LBD in conferring transactivational activity[J].J Clin Endocrinol Metab,2005,90(6):3696-3705.
  • 7赵蓓蕾,熊华,齐名,施毅.甘草和糖皮质激素对吸烟大鼠血清IL-8的影响[J].医学研究生学报,2006,19(3):232-234. 被引量:4
  • 8钱频,张芳,钱桂生,陈维中.脂多糖作用大鼠肺泡巨噬细胞糖皮质激素受体表达及活性变化[J].第三军医大学学报,2004,26(22):2042-2044. 被引量:13
  • 9Tanaka H.Nuclear receptor and inflammation[J].Nihon Rinsho Meneki Gakkai Kaishi,2002,25(3):233-249.
  • 10Siriani D,Mitsiou DJ,Alexis MN.Overexpressed glucocorticoid receptor negatively regulates gene expression under conditions that favour accumulation of non-hormone-binding forms of the receptor[J].J Steroid Biochem Mol Biol,2003,84(2-3):171-180.

二级参考文献13

  • 1Roe A L,Howard G,Blouin R A.Characterization of nuclear protein binding (AP-1,GR,and STAT) in the genetically obese (fa/fa) Zucker rat[J].Life Sci,1998,63(15):1339-1346.
  • 2Saklatvala J,Dean J,Clark A.Control of the expression of inflammatory response genes[J].Biochem Soc Symp,2003,72 (70):95-106.
  • 3Webster J C,Jewell C M,Bodwell J E,et al.Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein[J].J Biol Chem,1997,272(14):9287-9293.
  • 4Meduri G U,Tolley,E A,Chrousos G P,et al.Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome:evidence for inadequate endogenous glucocorticoid secretion and inflammation-
  • 5Kino T,De Martino M U,Charmandari E,et al.Tissue glucocorticoid resistance/hypersensitivity syndromes[J].J Steroid Biochem Mol Biol,2003,85(2-5):457-467.
  • 6Beeh KM,Kornmann O,Buhl R,et al.Neutrophil chemotactic activity of sputum from patients with COPD:role of interleukin 8 and leukotriene B4[J].Chest,2003,123(4):1240-1247.
  • 7Schulz C,Wolf K,Harth M,et al.Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease,smokers,and never-smokers[J].Respiration,2003,70(3):254-261.
  • 8Perng DW,Huang HY,Chen HM,et al.Characteristics of airway inflammation and bronchodilator reversibility in COPD:a potential guide to treatment[J].Chest,2004,126(2):375-381.
  • 9Mahler DA,Huang S,Tabrizi M,et al.Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD:a pilot study[J].Chest,2004,126(3):926-934.
  • 10Tanino M,Betsuyaku T,Takeyabu K,et al.Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema[J].Thorax,2002,57(5):405-411.

共引文献32

同被引文献8

  • 1Pujols L, Mullol J, Picado C. Importance of glucocorticoid receptors in upper and lower airways[J]. Front Biosci, 2010, 15:789-800.
  • 2Smoak KA, Cidlowski JA. Mechanisms of glucocorticoid receptor signaling during inflammation[J]. Mech Ageing Dev, 2004, 125(10- 11):697-706.
  • 3Charmandari E, Raji A, Kino T, et al. A novel point mutation in the ligand binding domain (LBD) o{ the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity[J]. J Clin Endocrinol Metab, 2005, 90(6): 3696-705.
  • 4Chung SK, Maiti KK, Lee WS. Recent advances in cell-penetrating, non-peptide molecular carriers[J]. Int J Pharm, 2008, 354 (1-2) 16-22.
  • 5Dimitriou AA, Stathopoulos P, Mitsios JV, et al. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(Ⅱb)beta(3) conjugated to the cell-penetrating peptide Tat (48-60)[J]. Platelets, 2009, 20(8): 539-547.
  • 6Manceur AP, Driscoll BD, Sun W, et al. Selective enhancement of the uptake and bioactivity of a TAT-conjugated peptide inhibitor of glycogen synthase kinase-3[J]. Mol Ther, 2009, 17(3): 500-507.
  • 7Ko YT, Hartner WC, Kale A, et al. Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide[J]. Gene Ther, 2009, 16(1): 52-59.
  • 8Black BE, Holaska JM, Rastinejad F, et al. DNA binding domains in diverse nuclear receptors function as nuclear export signals[J]. Curr Biol, 2001, 11(22): 1749-1758.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部